Terms: = Uterine cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118 AND Prognosis
1 results:
1. The lifr Inhibitor EC359 Effectively Targets Type II Endometrial cancer by Blocking LIF/lifr Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract] [Full Text] [Related]
